Roles of vitamin E in prostate and prostate cancer

Prostate Cancer: Basic Mechanisms and Therapeutic Approaches

Volumn , Issue , 2005, Pages 263-276

  Yeh, Shuyuan ^a   Ni, Jing ^a   Chang, Eugene ^a   Yin, Yi ^a   Chen, Ming ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84967702783     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789812569202_0011     Document Type: Chapter

References (50)

1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ (2004) Cancer statistics, 2004. CA Cancer J Clin 54:8-29.
2. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group (1994) The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330:1029-1035.
3. Kristal AR, Stanford JL, Cohen JH, Wicklund K, Patterson RE (1999) Vitamin and mineral supplement use is associated with reduced risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 8:887-892.
4. Chiu BC, Ji BT, Dai Q, Gridley G, McLaughlin JK, Gao YT, Fraumeni JF, Jr, Chow WH (2003) Dietary factors and risk of colon cancer in Shanghai, China. Cancer Epidemiol Biomarkers Prev 12:201-208.
5. Brigelius-Flohe R, Traber MG (1999) Vitamin E: function and metabolism. FASEB J 13:1145-1155.
6. Prasad KN, Kumar B, Yan XD, Hanson AJ, Cole WC (2003) Alpha-tocopheryl succinate, the most effective form of vitamin E for adjuvant cancer treatment: a review. J Am Coll Nutr 22:108-117.
7. Malafa MP, Neitzel LT (2000) Vitamin E succinate promotes breast cancer tumor dormancy. J Surg Res 93:163-170.
8. Fariss MW, Fortuna MB, Everett CK, Smith JD, Trent DF, Djuric Z (1994) The selective antiproliferative effects of alpha-tocopheryl hemisuccinate and cholesteryl hemisuccinate on murine leukemia cells result from the action of the intact compounds. Cancer Res 54:3346-3351.
9. Lawson KA, Anderson K, Menchaca M, Atkinson J, Sun L, Knight V, Gilbert BE, Conti C, Sanders BG, Kline K (2003) Novel vitamin E analogue decreases syngeneic mouse mammary tumor burden and reduces lung metastasis. Mol Cancer Ther 2:437-444.
10. Anderson K, Simmons-Menchaca M, Lawson KA, Atkinson J, Sanders BG, Kline K (2004) Differential response of human ovarian cancer cells to induction of apoptosis by vitamin E succinate and vitamin E analogue, alpha-TEA. Cancer Res 64:4263-4269.
11. Birringer M, Ey Tina JH, Salvatore BA, Neuzil J (2003) Vitamin E analogues as inducers of apoptosis: structure-function relation. Br J Cancer 88: 1948-1955.
12. Institute of Medicine (2000) Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. National Academies Press, Washington, DC.
13. Fleshner NE (2002) Vitamin E and prostate cancer. Urol Clin North Am 29:107-113, ix.
14. Huang HY, Appel LJ (2003) Supplementation of diets with alpha-tocopherol reduces serum concentrations of gamma- and delta-tocopherol in humans. JNutr 133:3137-3140.
15. Baker H, Handelman GJ, Short S, Machlin LJ, Bhagavan HN, Dratz EA, Frank O (1986) Comparison of plasma alpha and gamma tocopherol levels following chronic oral administration of either all-rac-alpha-tocopheryl acetate or RRR-alpha-tocopheryl acetate in normal adult male subjects. Am J Clin Nutr 43:382-387.
16. Bonina F, Lanza M, Montenegro L, Salerno L, Smeriglio P, Trombetta D, Saija A (1996) Transport of alpha-tocopherol and its derivatives through erythrocyte membranes. Pharm Res 13:1343-1347.
17. Zimmer S, Stocker A, Sarbolouki MN, Spycher SE, Sassoon J, Azzi A (2000) A novel human tocopherol-associated protein: cloning, in vitro expression, and characterization. J Biol Chem 275:25672-25680.
18. Dutta-Roy AK, Gordon MJ, Leishman DJ, Paterson BJ, Duthie GG, James WP (1993) Purification and partial characterisation of an alpha-tocopherol-binding protein from rabbit heart cytosol. Mol Cell Biochem 123:139-144.
19. Gordon MJ, Campbell FM, Duthie GG, Dutta-Roy AK (1995) Characterization of a novel alpha-tocopherol-binding protein from bovine heart cytosol. Arch Biochem Biophys 318:140-146.
20. Klein EA, Thompson IM, Lippman SM, Goodman PJ, Albanes D, Taylor PR, Coltman C (2001) SELECT: the next prostate cancer prevention trial. Selenum and Vitamin E Cancer Prevention Trial. J Urol 166:1311-1315.
21. Klein EA, Lippman SM, Thompson IM, Goodman PJ, Albanes D, Taylor PR, Coltman C (2003) The selenium and vitamin E cancer prevention trial. World J Urol 21:21-27.
22. Sigounas G, Anagnostou A, Steiner M (1997) dl-alpha-tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells. Nutr Cancer 28:30-35.
23. Gunawardena K, Murray DK, Meikle AW (2000) Vitamin E and other antioxidants inhibit human prostate cancer cells through apoptosis. Prostate 44:287-295.
24. Israel K, Yu W, Sanders BG, Kline K (2000) Vitamin E succinate induces apoptosis in human prostate cancer cells: role for Fas in vitamin E succinate- triggered apoptosis. Nutr Cancer 36:90-100.
25. Ni J, Chen M, Zhang Y, Li R, Huang J, Yeh S (2003) Vitamin E succinate inhibits human prostate cancer cell growth via modulating cell cycle regulatory machinery. Biochem Biophys Res Commun 300:357-363.
26. Venkateswaran V Fleshner NE, Klotz LH (2002) Modulation of cell proliferation and cell cycle regulators by vitamin E in human prostate carcinoma cell lines. J Urol 168:1578-1582.
27. Gysin R, Azzi A, Visarius T (2002) Gamma-tocopherol inhibits human cancer cell cycle progression and cell proliferation by down-regulation of cyclins. FASEB J 16:1952-1954.
28. Heinlein CA, Chang C (2002) Androgen receptor (AR) coregulators: an overview. Endocr Rev 23:175-200.
29. Yeh S, Kang HY, Miyamoto H, Nishimura K, Chang HC, Ting HJ, Rahman M, Lin HK, Fujimoto N, Hu YC, Mizokami A, Huang KE, Chang C (1999) Differential induction of androgen receptor transactivation by different androgen receptor coactivators in human prostate cancer DU145 cells. Endocrine 11:195-202.
30. Yeh S, Lin HK, Kang HY, Thin TH, Lin MF, Chang C (1999) From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. Proc Natl Acad Sci USA 96:5458-5463.
31. Zhang Y, Ni J, Messing EM, Chang E, Yang CR, Yeh S (2002) Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells. Proc Natl Acad Sci USA 99:7408-7413.
32. Zhang M, Altuwaijri S, Yeh S (2004) RRR-alpha-tocopheryl succinate inhibits human prostate cancer cell invasiveness. Oncogene 23:3080-3088.
33. Wilson MJ, Kaye D, Smith WE, Quach HT, Sinha AA, Vatassery GT (2003) Effect of vitamin E deficiency on the growth and secretory function of the rat prostatic complex. Exp Mol Pathol 74:267-275.
34. Nakamura A, Shirai T, Takahashi S, Ogawa K, Hirose M, Ito N (1991) Lack of modification by naturally occurring antioxidants of 3,2'-dimethyl-4- aminobiphenyl-initiated rat prostate carcinogenesis. Cancer Lett 58:241-246.
35. Fleshner N, Fair WR, Huryk R, Heston WD (1999) Vitamin E inhibits the high-fat diet promoted growth of established human prostate LNCaP tumors in nude mice. J Urol 161:1651-1654.
36. Nesbitt JA, Smith J, McDowell G, Drago JR (1988) Adriamycin-vitamin E combination therapy for treatment of prostate adenocarcinoma in the Nb rat model. J Surg Oncol 38:283-284.
37. Venkateswaran V Fleshner NE, Sugar LM, Klotz LH (2004) Antioxidants block prostate cancer in lady transgenic mice. Cancer Res 64:5891-5896.
38. Hartman TJ, Albanes D, Pietinen P, Hartman AM, Rautalahti M, Tangrea JA, Taylor PR (1998) The association between baseline vitamin E, selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol Biomarkers Prev 7:335-340.
39. Huang HY, Alberg AJ, Norkus EP, Hoffman SC, Comstock GW, Helzlsouer KJ (2003) Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am J Epidemiol 157:335-344.
40. Helzlsouer KJ, Huang HY, Alberg AJ, Hoffman S, Burke A, Norkus EP, Morris JS, Comstock GW (2000) Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst 92:2018-2023.
41. Chan JM, Stampfer MJ, Ma J, Rimm EB, Willett WC, Giovannucci EL (1999) Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States. Cancer Epidemiol Biomarkers Prev 8:893-899.
42. Hartman TJ, Dorgan JF, Virtamo J, Tangrea JA, Taylor PR, Albanes D (1999) Association between serum alpha-tocopherol and serum androgens and estrogens in older men. Nutr Cancer 35:10-15.
43. Woodson K, Triantos S, Hartman T, Taylor PR, Virtamo J, Albanes D (2002) Long-term alpha-tocopherol supplementation is associated with lower serum vascular endothelial growth factor levels. Anticancer Res 22:375-378.
44. Greenberg NM, DeMayo FJ, Sheppard PC, Barrios R, Lebovitz R, Finegold M, Angelopoulou R, Dodd JG, Duckworth ML, Rosen JM, et al. (1994) The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice. Mol Endocrinol 8:230-239.
45. Kasper S, Sheppard PC, Yan Y, Pettigrew N, Borowsky AD, Prins GS, Dodd JG, Duckworth ML, Matusik RJ (1998) Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer. Lab Invest 78:319-333.
46. Masumori N, Thomas TZ, Chaurand P, Case T, Paul M, Kasper S, Caprioli RM, Tsukamoto T, Shappell SB, Matusik RJ (2001) A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential. Cancer Res 61:2239-2249.
47. Bhatia-Gaur R, Donjacour AA, Sciavolino PJ, Kim M, Desai N, Young P, Norton CR, Gridley T, Cardiff RD, Cunha GR, Abate-Shen C, Shen MM (1999) Roles for Nkx3.1 in prostate development and cancer. Genes Dev 13:966-977.
48. Kim MJ, Cardiff RD, Desai N, Banach-Petrosky WA, Parsons R, Shen MM, Abate-Shen C (2002) Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci USA 99:2884-2889.
49. Leonard SW, Terasawa Y, Farese RV Jr, Traber MG (2002) Incorporation of deuterated RRR- or all-rac-alpha-tocopherol in plasma and tissues of alpha-tocopherol transfer protein-null mice. Am J Clin Nutr 75:555-560.
50. Ouahchi K, Arita M, Kayden H, Hentati F, Ben Hamida M, Sokol R, Arai H, Inoue K, Mandel JL, Koenig M (1995) Ataxia with isolated vitamin E deficiency is caused by mutations in the alpha-tocopherol transfer protein. Nat Genet 9:141-145.